MYNZ Mainz Biomed B.V.
1,440
$0.66
$0.001
(0.15%)
| Watchers | 1,440 |
| 52-Wk Low | $0.65 |
| 52-Wk High | $6.00 |
| Market Cap | $14.42M |
| Volume | 56,646.00 |
| 52-Wk High | $6.00 |
| 52-Wk Low | $0.65 |
Mainz Biomed to organize HALLO DOC! eventThe Fly • about 2 months ago
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Share to Feed
BERKELEY, Calif. and MAINZ, Germany, March 19, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ( Mainz Biomed or the Company ), a leader in molecular genetics diagnostic solutions for...
BERKELEY, Calif. and MAINZ, Germany, March 18, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ( Mainz Biomed or the Company ), a leader in molecular genetics diagnostic solutions for...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
BERKELEY, Calif. and MAINZ, Germany, March 12, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ( Mainz Biomed or the Company ), a leader in molecular genetics diagnostic solutions for...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Dr. Jay Wohlgemuth, former Chief Medical & Scientific Officer of Quest Diagnostics and Dr. Ray Tabibiazar, a seasoned industry executive, to lead collaborationMainz Biomed's Pivotal FDA PMA clinical...
BERKELEY, Calif. and MAINZ, Germany, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ( Mainz Biomed or the Company ), a leader in molecular genetics diagnostic solutions for...
BERKELEY, Calif. and MAINZ, Germany, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) ( Mainz Biomed or the Company ), a leader in molecular genetics diagnostic solutions for...